Table 1.
Sample | Formulations | Cetyl palmitate | Precirol ATO 5 | Oleic acid | Miglyol 812 | Polysorbate 60 | Minoxidil | Finasteride |
---|---|---|---|---|---|---|---|---|
NLC A | Minoxidil free NLC | 671.5 | – | 288 | – | 50.5 | 0 | – |
NLC B | 2% Minoxidil loaded NLC | 651.5 | – | 288 | – | 50.5 | 20 | – |
NLC C | 3% Minoxidil loaded NLC | 641.5 | – | 288 | – | 50.5 | 30 | – |
NLC D | Finasteride free NLC | – | 350 | – | 150 | 100 | – | 0 |
NLC E | 0.8% Finasteride loaded NLC | – | 345 | – | 150 | 100 | – | 5 |
NLC F | 2% Finasteride loaded NLC | – | 337.5 | – | 150 | 100 | – | 12.5 |
Notes: Precirol® ATO 5: Gattefossé, Lyon, France; Miglyol® 812: Acofarma, Madrid, Spain.
Abbreviation: NLC, nanostructured lipid carrier.